Teladoc health, inc. (TDOC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14Jun'14
Revenue

180,799

156,489

137,969

130,276

128,573

122,741

110,962

94,560

89,644

77,140

68,650

44,591

42,898

37,400

32,381

26,488

26,888

22,640

19,973

18,283

16,488

10,905

10,289

Expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)

72,382

55,355

42,799

41,634

44,677

40,028

34,167

27,684

26,856

22,716

16,742

10,026

12,139

10,025

7,112

6,891

7,943

6,479

4,488

4,793

5,281

2,151

2,027

Gross profit

-

-

-

-

-

-

-

-

-

54,424

51,908

34,565

30,759

27,375

25,269

19,597

18,945

16,161

15,485

13,490

11,207

8,754

8,262

Operating expenses:
Advertising and marketing

32,515

25,356

31,321

26,616

26,404

23,555

21,668

19,561

20,325

18,441

14,328

12,278

12,616

9,820

9,046

7,804

8,050

5,881

5,284

4,730

4,341

1,984

1,436

Sales

17,940

16,751

16,120

15,832

16,212

14,509

16,303

14,559

13,783

11,279

11,393

7,324

7,988

7,451

7,662

5,860

5,270

4,786

5,111

4,397

3,682

3,263

3,033

Technology and development

19,257

16,246

15,746

16,665

15,987

13,544

13,577

14,348

12,904

10,446

9,964

7,537

6,512

5,894

5,867

4,829

5,225

4,160

3,941

3,203

2,906

1,960

2,064

Legal and regulatory

1,222

1,523

1,634

2,019

1,586

1,490

807

639

1,045

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Legal

-

-

-

-

-

-

-

-

-

760

105

277

343

769

1,033

1,193

1,122

-

1,421

5,332

-

-

-

Regulatory

-

-

-

-

-

-

-

-

-

616

777

987

1,007

721

817

772

848

-

740

733

-

-

-

Acquisition and integration related costs

3,664

2,477

1,995

1,136

1,012

1,434

1,588

5,800

1,569

2,557

8,526

2,113

-

-

6,196

763

-

-

15

-

-

-

-

Gain on sale

-

0

0

0

-

0

1,430

4,070

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

45,120

44,482

38,681

38,549

35,982

36,461

30,314

26,140

24,001

27,482

21,938

15,873

14,488

13,353

12,298

11,280

11,637

10,513

10,077

10,423

11,968

4,754

4,033

Depreciation and amortization

9,710

9,887

9,617

9,848

9,600

9,557

9,746

8,046

8,253

7,402

6,418

2,668

2,607

2,597

2,607

1,558

1,508

1,546

1,491

923

903

650

554

Total expenses

201,810

172,077

157,913

152,299

151,460

140,578

126,740

112,707

108,736

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-21,011

-15,588

-19,944

-22,023

-22,887

-17,837

-15,778

-18,147

-19,092

-24,559

-21,541

-14,492

-14,802

-13,230

-20,257

-14,462

-14,715

-14,346

-12,595

-16,251

-12,593

-3,857

-2,858

Amortization of warrants and loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

12,665

1,457

-

-

-

8,454

-

-

-

-

-

-

-

-

Interest expense, net

-9,303

-7,581

-7,700

-7,211

-6,521

-6,663

-7,666

-6,910

-4,873

-7,813

-8,202

-774

-702

-881

-873

-407

-427

-500

-489

-642

-568

-510

-349

Net loss before taxes

-30,314

-23,169

-27,644

-29,234

-29,408

-24,500

-23,444

-25,057

-23,965

-45,037

-31,200

-15,266

-15,504

-14,111

-29,584

-14,869

-15,142

-14,846

-13,084

-16,893

-13,161

-4,367

-3,207

Income tax (benefit) expense

-700

-4,125

-7,298

90

742

379

-180

22

-103

-654

130

149

150

150

188

10

162

161

162

171

-458

162

-7

Net loss

-29,603

-19,044

-20,346

-29,324

-30,150

-24,879

-23,264

-25,079

-23,862

-44,383

-31,330

-15,415

-15,654

-14,261

-29,772

-14,879

-15,304

-15,007

-13,246

-17,064

-12,703

-4,529

-3,200

Preferred stock dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

834

1,055

Accretion of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

168

-

Net loss available to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,531

-4,255

Net loss per share, basic and diluted

-0.40

-0.26

-0.28

-0.41

-0.43

-0.35

-0.34

-0.40

-0.39

-0.76

-0.55

-0.28

-0.30

-0.31

-0.65

-0.38

-0.40

10.53

-0.37

-7.20

-5.87

-2.68

-2.15

Weighted-average shares used to compute basic and diluted net loss per share

73,278

72,565

72,151

71,721

70,919

70,240

68,248

62,976

61,798

58,371

56,493

54,573

52,193

46,082

45,860

38,717

38,584

39,037

36,099

2,370

2,162

2,060

1,974